Fredric N. Eshelman's Insider Trades & SAST Disclosures
Fredric N. Eshelman's most recent trade in Aravive Inc was a trade of 16,306,120 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on Oct. 24, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Fredric N. Eshelman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aravive Inc | Fredric N. Eshelman | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.92 per share. | 24 Oct 2022 | 16,306,120 | 25,517,889 (170%) | 109% | 0.9 | 15,000,000 | Common Stock |
| Aravive Inc | Fredric N. Eshelman | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 8,153,060 | 8,153,060 | - | - | Series B Warrants (right to buy) | |
| Aravive Inc | Fredric N. Eshelman | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Oct 2022 | 8,153,060 | 8,153,060 | - | - | Series A Warrants (right to buy) | |
| Aravive Inc | Fredric N. Eshelman | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Sep 2022 | 97,063 | 97,063 | - | - | Stock Option (Right to Buy) | |
| Aravive Inc | Fredric N. Eshelman | Director, Executive Chairman of Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 4,545,455 | 9,211,769 (61%) | 30% | 0.0 | 455 | Common Stock |
| Aravive Inc | Fredric N. Eshelman | Director, Executive Chairman of Board, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 4,545,455 | 0 | - | - | Pre-Funded Warrant (right to buy) | |
| Aravive Inc | Fredric N. Eshelman | Director, Executive Chairman of Board, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 860,216 | 860,216 | - | - | Warrant (right to buy) | |
| Aravive Inc | Fredric N. Eshelman | Director, Executive Chairman of Board, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 2.32 per share. | 29 Mar 2022 | 860,216 | 4,666,314 (31%) | 5% | 2.3 | 2,000,002 | Common Stock |
| Aravive Inc | Fredric N. Eshelman | Director, Executive Chairman of Board, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 4,545,455 | 4,545,455 | - | - | Pre-Funded Warrant (right to buy) | |
| Eyenovia Inc | Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 9,653 | 9,653 | - | - | Stock Option (right to buy) | |
| Eyenovia Inc | Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 6,963 | 1,299,750 (7%) | 0% | 0 | Common Stock, par value $.0001 | |
| Aravive Inc | Fredric N. Eshelman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 22,812 | 22,812 | - | - | Stock Option | |
| Aravive Inc | Fredric N. Eshelman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 7.29 per share. | 12 Feb 2021 | 2,875,000 | 3,806,098 (25%) | 19% | 7.3 | 20,958,750 | Common stock |
| Aravive Inc | Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2020 | 16,029 | 16,029 | - | - | Stock Option | |
| Eyenovia Inc | Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2020 | 9,820 | 9,820 | - | - | Stock Option (right to buy) | |
| Eyenovia Inc | Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2020 | 7,288 | 1,292,787 (7%) | 0% | 0 | Common Stock, par value $.0001 | |
| G1 Therapeutics Inc | Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Aravive Inc | Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 7,500 | 7,500 | - | - | Stock Option | |
| Aravive Inc | Fredric N. Eshelman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 3,226 | 3,226 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges